Skip to main content
Equibles

BARCLAYS PLC

Position in PHAT — Phathom Pharmaceuticals, Inc.

CIK 312069 LONDON, X0
Back to PHAT Full portfolio

Position in PHAT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$453,280
+$171,565 QoQ
Shares Held
41,777
+64.8% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 161 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PHAT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. PHAT ranks #175 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in PHAT

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $453,280 41,777
2026-03-31 $281,715 25,357
2025-12-31 $1,407,810 84,859
2025-09-30 $1,510,749 128,356
2025-06-30 $788,008 82,170
2025-03-31 $344,235 54,902
2024-12-31 $620,879 76,463
2024-09-30 $1,045,150 57,807
2024-06-30 $127,771 12,405
2024-03-31 $299,473 28,199
2023-12-31 $453,505 49,672
2023-09-30 $137,246 13,235
2023-06-30 $154,842 10,813
2023-03-31 $89,435 12,526
2022-12-31 $99,622 8,879
2022-09-30 $10,814 976
2022-06-30 $40,233 4,767
2022-03-31 $94,820 6,967